Product Description: IRX5010 (IRX4647F), an analogue of IRX4647, is a highly selective RARγ nuclear receptor agonist. IRX5010 demonstrates inhibition of in vivo growth of EMT-6 triple negative breast cancer[1].
Applications: Cancer-programmed cell death
Formula: C24H26FNO3
References: [1]Sanders M E, et al. IRX5010 (IRX4647F), a Highly Selective RARγ Nuclear Receptor Agonist Compound Inhibits In Vivo Growth of Murine EMT-6 Triple Negative Breast Cancer and Human JIMT-1 Her2+ Breast Cancer By Induction of Tumor-Infiltrating Effector Memory T-cells[J].
CAS Number: 856683-59-5
Molecular Weight: 395.47
Research Area: Cancer
Target: RAR/RXR